Delivery Order SPE2DB24D9249-SPE2DB25FGLFT
Award Date
6/26/25
Potential Completion Date
7/18/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,499.90 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, with a period of performance through July 16, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, with a completion date of June 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, is for the supply of STELARA 90 MG/ML SYRINGE. The contract has a firm fixed price of $16,249.95 and a period of performance through July 23, 2025. DMS Pharmaceutical Group Inc. has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The award is not associated with a set-aside program and has an ultimate completion date of August 5, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $324,999.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide STELARA 90 MG/ML syringes. The contract has an ultimate completion date of July 24, 2025. DMS Pharmaceutical Group is a pharmaceutical wholesaler that specializes in supplying medical products to federal agencies, particularly the military healthcare system. This delivery order is part of a larger $499,999,999 Indefinite...
The federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $32,499.90, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price and an ultimate completion date of July 22, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,882.72 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of June 5, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,441.36 contract is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,499.90 contract is for the delivery of STELARA 90 MG/ML SYRINGEML medication, with a period of performance ending on July 30, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order contract is for the supply of STELARA 90 MG/ML SYRINGE, a prescription medication, with an ultimate completion date of August 1, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...